New Delhi November 23,2013:
Biocad is a biopharmaceutical company, is a leader in Russian companies when it comes to the number of trials conducted. The company has a well established laboratory and equipment. Biocad is involved in development of biotechnological products that range from genetic engineering to preclinical testing.
Biocad, this week was successful in obtaining a good manufacturing practice (GMP) certificate in Ukraine. This certificate proves to be important for the company. It confirms that the company’s manufacturing plant in Moscow region meets the standards good manufacturing practice (GMP) norms.
The company deals with biological and biotech products. The areas in which it predominantly focuses include reproductive health, autoimmune health, viral infection and hematology and oncology. The company has clinical research studies being conducted in countries like Russia, Ukraine, India and Belarus. CCI Newswire
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…